Weekly CEO News from Richard Ingram
May 13, 2016

USDCHF: With the dollar/franc pair taking back all of its earlier losses for the week to close higher on Friday, more strength is expected in the new week. On the downside, support lies at the 0.9700 level. A turn below

Read more

We all fuss about government waste, corruption and criminal activity related to the U.S. government and their Wall St associates. The activities, which report on daily, are nothing short of inhumane as the unproductive capital that is wasted or looted

Read more

Running length 00:34:29

Before you raise your voice, please allow me to say that I do indeed know this starts to feel like a set of Russian dolls, and this is a re-run of a re-run. It’s just, I didn’t start it. Got

Read more

The market has been bifurcated for quite some time with froth leading lower while the Sp and Dow try to hold up the market. Money has been rotating in to the Sp because that’s where lower froth, lower p/e and higher

Read more

The following investment idea is VERY RISKY.  ACCEPT THE FACT YOU COULD LOSE YOUR ENTIRE INVESTMENT. If this makes sense to you, buy in-the-money puts.     Motor vehicle sales were an 18.1 million annual rate in December 2015. They fell to

Read more

Let’s take a closer look at US Treasuries since the Fed’s December rate hike decision, the first increase in a decade. The yield on the 10-year note ended the day today at 1.71%, which is at the low end of

Read more

I did a technical video of the markets and where we stand going forward.  I reviewed the following: SPY, QQQ, IWM, DIA, GLD, SLV, USO, FB, AMZN, NFLX, GOOGL, AAPL, XLE, GM, LNKD Enjoy! (Video length 00:16:11)

With nearly $286 billion of assets under management, The Dreyfus Corporation is considered as one of the leaders in the investment management and distribution domain in the U.S. Founded in 1951, the company invests its assets in mutual funds from

Read more

Gilead (GILD) is no longer the biggest biotech by market cap in the world, a position now occupied by Amgen (AMGN), but the bearish news may not stop there. JPMorgan analyst Cory Kasimov says Gilead’s shares look cheap, but may

Read more